BenQ Medical Technology Corporation

TPEX:4116 Stock Report

Market Cap: NT$2.1b

BenQ Medical Technology Past Earnings Performance

Past criteria checks 4/6

BenQ Medical Technology has been growing earnings at an average annual rate of 16.7%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 32% per year. BenQ Medical Technology's return on equity is 11%, and it has net margins of 2.5%.

Key information

16.7%

Earnings growth rate

16.7%

EPS growth rate

Medical Equipment Industry Growth11.5%
Revenue growth rate32.0%
Return on equity11.0%
Net Margin2.5%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

There's Been No Shortage Of Growth Recently For BenQ Medical Technology's (GTSM:4116) Returns On Capital

Apr 07
There's Been No Shortage Of Growth Recently For BenQ Medical Technology's (GTSM:4116) Returns On Capital

Estimating The Fair Value Of BenQ Medical Technology Corporation (GTSM:4116)

Mar 23
Estimating The Fair Value Of BenQ Medical Technology Corporation (GTSM:4116)

BenQ Medical Technology's (GTSM:4116) Shareholders Are Down 49% On Their Shares

Mar 08
BenQ Medical Technology's (GTSM:4116) Shareholders Are Down 49% On Their Shares

Does BenQ Medical Technology Corporation (GTSM:4116) Have A Place In Your Dividend Stock Portfolio?

Feb 17
Does BenQ Medical Technology Corporation (GTSM:4116) Have A Place In Your Dividend Stock Portfolio?

BenQ Medical Technology (GTSM:4116) Seems To Use Debt Quite Sensibly

Jan 29
BenQ Medical Technology (GTSM:4116) Seems To Use Debt Quite Sensibly

BenQ Medical Technology Corporation's (GTSM:4116) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?

Jan 11
BenQ Medical Technology Corporation's (GTSM:4116) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?

The Returns At BenQ Medical Technology (GTSM:4116) Provide Us With Signs Of What's To Come

Dec 24
The Returns At BenQ Medical Technology (GTSM:4116) Provide Us With Signs Of What's To Come

BenQ Medical Technology's (GTSM:4116) Shareholders Are Down 72% On Their Shares

Dec 07
BenQ Medical Technology's (GTSM:4116) Shareholders Are Down 72% On Their Shares

Should You Buy BenQ Medical Technology Corporation (GTSM:4116) For Its 4.4% Dividend?

Nov 17
Should You Buy BenQ Medical Technology Corporation (GTSM:4116) For Its 4.4% Dividend?

Revenue & Expenses Breakdown

How BenQ Medical Technology makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TPEX:4116 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244,6571161,03333
30 Jun 244,59712699732
31 Mar 244,54611596632
31 Dec 234,54311594832
30 Sep 234,50610193734
30 Jun 234,4679891237
31 Mar 234,81611593538
31 Dec 224,37718085740
30 Sep 223,62416974939
30 Jun 222,88514363938
31 Mar 221,74811247337
31 Dec 211,4652942540
30 Sep 211,4554841242
30 Jun 211,4455441444
31 Mar 211,4325941845
31 Dec 201,4016241044
30 Sep 201,3495439544
30 Jun 201,3315938845
31 Mar 201,3486339146
31 Dec 191,3807539045
30 Sep 191,3708038542
30 Jun 191,3317736740
31 Mar 191,3078235138
31 Dec 181,2336733438
30 Sep 181,1545531239
30 Jun 181,1444930941
31 Mar 181,0854529044
31 Dec 171,0374726746
30 Sep 179854424450
30 Jun 179014221051
31 Mar 178714319952
31 Dec 168764619855
30 Sep 169222322071
30 Jun 169132222072
31 Mar 1692511522877
31 Dec 1593811822777
30 Sep 1595114920967
30 Jun 151,02216721569
31 Mar 151,0468220867
31 Dec 141,0157820168
30 Sep 149456918364
30 Jun 148695716362
31 Mar 148064316259
31 Dec 138064216957

Quality Earnings: 4116 has high quality earnings.

Growing Profit Margin: 4116's current net profit margins (2.5%) are higher than last year (2.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 4116's earnings have grown by 16.7% per year over the past 5 years.

Accelerating Growth: 4116's earnings growth over the past year (14.7%) is below its 5-year average (16.7% per year).

Earnings vs Industry: 4116 earnings growth over the past year (14.7%) exceeded the Medical Equipment industry 5%.

Return on Equity

High ROE: 4116's Return on Equity (11%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 10:12
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BenQ Medical Technology Corporation is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pinghan HsiehCapital Securities Corporation
Shih-Hao TsengJih Sun Securities Investment Consulting Co., Ltd.